Prostate cancer is the leading cause of cancer-related deaths in men of Western countries. New diagnostic devices are required for correct diagnosis and prediction of treatment outcome.
More than a quarter of prostate cancer patients relapse after five years of surgery. Although diagnosis takes place at early stages, prognosis is difficult due to the lack of predictive biomarkers for clinical outcome and treatment response.
Further information: Novel prostate cancer diagnostic devices for improved treatment